JAK2 and esophageal squamous cell carcinoma: In esophageal squamous cell carcinoma, CAFs secrete WNT2 to inhibit the SOCS3/p‐JAK2/p‐STAT3 pathway, thereby suppressing CD8+ T‐cell activation [99].